Cardiac natriuretic peptides after myocardial infarction: relationship with infarct size, left ventricular function and remodelling assessed by 99mTc-sestamibi gated-single photon emission tomography
-
Luca Ceriani
Abstract
Background: The aim of the study was to investigate the potential relationship between A-type (atrial) and B-type (brain) natriuretic peptides (ANP, BNP) and infarct size (IS), left ventricular (LV) function and remodelling as assessed by 99m technetium-hexakis-2-methoxy-isobutyl-isonitrile (99mTc-sestamibi) gated-single photon emission tomography (G-SPET).
Methods: Plasma concentrations of ANP and BNP in peripheral blood were measured in 54 patients with coronary artery disease (CAD) and previous myocardial infarction (MI). Of these, 25 subjects had a recent (<2 weeks) and 29 subjects an old (>6 months) MI. IS, left ventricular ejection fraction (LVEF) and end diastolic (EDV), end systolic (ESV) and stroke volume (SV) were quantitatively calculated from at-rest G-SPET.
Results: In either univariate or multivariate regression analysis that included IS and the other G-SPET derived parameters as co-variables, both BNP and ANP showed a significant association with IS (BNP p<0.002; ANP p<0.01). No significant relationship was found between the two peptides and LVEF, EDV or ESV values. BNP, but not ANP concentrations, were significantly higher in patients with antero-septal vs. infero-lateral (p=0.01) and recent vs. old MI (p=0.003). In these two subgroups, univariate and multivariate analyses confirmed the correlation between BNP and IS, whereas ANP demonstrated a relationship with IS only in subjects with recent MI. CAD extent had no influence on BNP and ANP levels.
Conclusions: The present study showed a positive correlation between BNP and the perfusion defect measured by 99mTc-sestamibi G-SPET in patients with previous MI. Consequently, BNP may reflect the functional significance of myocardial damage and may be considered of prognostic value. ANP was also related to scintigraphic defects in the early phase after MI, but not in the chronic phase, confirming that ANP is a less sensitive marker of LV remodelling, depending also on atrial load conditions and dilatation. These preliminary data based on a small group of subjects need to be confirmed by prospective longitudinal studies involving larger populations.
Clin Chem Lab Med 2007;45:226–31.
References
1. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation1987;76:44–51.10.1161/01.CIR.76.1.44Suche in Google Scholar
2. Chareonthaitawee P, Christian TF, Hirose K, Gibbons RJ Rumberger JA. Relation of initial infarct size to extent of left ventricular remodelling in the year after acute myocardial infarction. J Am Coll Cardiol1995;25:567–73.10.1016/0735-1097(94)00431-OSuche in Google Scholar
3. Becker LC, Silverman KJ, Bulkley BH, Kallman CH, Mellits ED, Weisfeldt M. Comparison of early thallium-201 scintigraphy and gated blood pool imaging for predicting mortality in patients with acute myocardial infarction. Circulation1983;67:1272–82.10.1161/01.CIR.67.6.1272Suche in Google Scholar
4. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation1995;92:334–41.10.1161/01.CIR.92.3.334Suche in Google Scholar
5. Cerqueira MD, Maynard C, Ritchie JL, Davis KB, Kennedy JW. Long term survival in 618 patients from Western Washington Streptokinase Myocardial Infarction trials. J Am Coll Cardiol1992;20:1452–9.10.1016/0735-1097(92)90436-QSuche in Google Scholar
6. Perez-Gonzales J, Botvinick EH, Dunn R, Rahimtoola S, Ports T, Chatterjee K, et al. The late prognostic value of acute scintigraphic measurement of myocardial infarction size. Circulation1982;66:960–71.10.1161/01.CIR.66.5.960Suche in Google Scholar
7. De Bold AJ. Atrial natriuretic factor a hormone produced by the heart. Science1985;230:767–70.10.1126/science.2932797Suche in Google Scholar PubMed
8. Yoshimura M, Yasue H, Morita E, Sakaino M, Jougasaki M, Kurose M, et al. Hemodynamic, renal and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation1991;84:1581–8.10.1161/01.CIR.84.4.1581Suche in Google Scholar PubMed
9. Mukoyama M, Nakao K, Hosoda K, Suga S, Saito Y, Ogawa Y, et al. Brain natriuretic peptide as novel cardiac hormone in human: evidence for an exquisite dual natriuretic peptide system, ANP and BNP. J Clin Invest1991;87:1402–12.10.1172/JCI115146Suche in Google Scholar PubMed PubMed Central
10. Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, et al. Localization and mechanisms of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation1994;90:195–203.10.1161/01.CIR.90.1.195Suche in Google Scholar
11. Saito Y, Nakao K, Arai H, Nishimura K, Okumura K, Obata K, et al. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest1989;83:289–305.10.1172/JCI113872Suche in Google Scholar
12. Morita E, Yasue H, Yoshimura M, Ogawa H, Jougasaki M, Matsumura T, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation1993;88:82–91.10.1161/01.CIR.88.1.82Suche in Google Scholar
13. Mukoyama M, Nakao K, Obata K, Jougasaki M, Yoshimura M, Morita E, et al. Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochem Biophys Res Commun1991;180:431–6.10.1016/S0006-291X(05)81311-7Suche in Google Scholar
14. Jougasaky M, Yasue H, Mukoyama M, Nakao K, Takahashi K. Appearance of atrial natriuretic peptide in patients with myocardial infarction. Am Heart J1990;119:92–6.10.1016/S0002-8703(05)80087-0Suche in Google Scholar
15. Sumida H, Yasue H, Yoshimura M, Okumura K, Ogawa H, Kugiyama K, et al. Comparison of secretion pattern between A-type and B-type natriuretic peptides in patients with old myocardial infarction. J Am Coll Cardiol1995;25:1105–10.10.1016/0735-1097(94)00525-USuche in Google Scholar
16. Arakawa N, Nakamura M, Aoki H, Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. J Am Coll Cardiol1996;27:1656–61.10.1016/0735-1097(96)00067-8Suche in Google Scholar
17. Darbar D, Davidson NC, Gillespie N, Choy AM, Lang CC, Shyr Y, et al. Diagnostic value of B-type natriuretic peptide concentrations in patients with acute myocardial infarction. Am J Cardiol1996;78:284–7.10.1016/S0002-9149(96)00278-0Suche in Google Scholar
18. Svanegaard J, Angelo-Nielsen K, Pindborg T. Plasma concentration of atrial natriuretic peptide at admission and risk of cardiac death in patients with acute myocardial infarction. Br Heart J1992;68:38–42.10.1136/hrt.68.7.38Suche in Google Scholar
19. Omland T, Aakvaag A, Bonarjee VV, Caidahi K, Lie RT, Nilsen DW, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation1996;93:1963–9.10.1161/01.CIR.93.11.1963Suche in Google Scholar
20. Nagaya N, Nishikimi T, Goto Y, Miyao Y, Kobayashi Y, Morii I, et al. Plasma natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodelling after acute myocardial infarction. Am Heart J1998;135:21–8.10.1016/S0002-8703(98)70338-2Suche in Google Scholar
21. Crilley JG, Farrer M. Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction. Heart2001;86:638–4210.1136/heart.86.6.638Suche in Google Scholar PubMed PubMed Central
22. Ceriani L, Verna E, Giovanella L, Bianchi L, Roncari G, Tarolo GL. Assessment of myocardial area at risk by technetium-99m sestamibi during coronary artery occlusion: comparison between three tomographic methods of quantification. Eur J Nucl Med1996;23:31–9.10.1007/BF01736987Suche in Google Scholar PubMed
23. Hama N, Itoh H, Shirakami G, Nakagawa O, Suga S, Ogawa Y, et al. Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. Circulation1995;92:1558–64.10.1161/01.CIR.92.6.1558Suche in Google Scholar PubMed
24. Thompson NL, Bazoberry F, Speier EH, Cassells W, Ferrans VJ, Flanders KC, et al. Transforming growth factor beta-1 in acute myocardial infarction in rats. Growth Factors1988;1:91–9.10.3109/08977198809000251Suche in Google Scholar PubMed
25. Chiba M, Bazoberry F, Speier EH, Sasse J, Nesbitt CP, Baird A, et al. Role of basic fibroblast growth factors in angiogenesis, healing and hypertrophy after rat myocardial infarction [abstract]. Circulation1989;80(Suppl II):II-452.Suche in Google Scholar
26. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, et al. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β: possible existence of vascular natriuretic peptide system. J Clin Invest1992;90:1145–9.10.1172/JCI115933Suche in Google Scholar PubMed PubMed Central
27. Nagaya N, Goto Y, Nishikimi T, Uematsu M, Miyao Y, Kobayashi Y, et al. Sustained plasma natriuretic peptide is a biochemical marker for the prediction of progressive ventricular remodelling after acute myocardial infarction. Clin Sci1999;96:129–36.10.1042/CS19980111Suche in Google Scholar
28. Panteghini M, Cuccia C, Bonetti G, Pagani F, Giubbini R, Bonini E. Rapid determination of brain natriuretic peptide in patients with acute myocardial infarction. Clin Chem Lab Med2003;41:164–8.10.1515/CCLM.2003.027Suche in Google Scholar PubMed
29. Nakagawa K, Umetani K, Fujioka D, Sano K, Nakamura T, Kodama Y, et al. Correlation of plasma concentrations of B-type natriuretic peptide with infarct size quantified by tomographic thallium-201 myocardial scintigraphy in asymptomatic patients with previous myocardial infarction. Circ J2004;68:923–7.10.1253/circj.68.923Suche in Google Scholar PubMed
30. Paelinck BP, Vrints CJ, Bax JJ, Bosman JM, De Hert SG, de Roos A, et al. Relation of B-type natriuretic peptide early after acute myocardial infarction to left ventricular diastolic function and extent of myocardial damage determined by magnetic resonance imaging. Am J Cardiol2006;15:1146–50.10.1016/j.amjcard.2005.11.030Suche in Google Scholar PubMed
31. Otterstad JE, St John Sutton MG, Froeland GS, Holme I, Shiaerpe T, Hall C. Prognostic value of two dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Eur Heart J2002;23:1011–20.10.1053/euhj.2001.2969Suche in Google Scholar PubMed
32. Hirayama A, Kusuoka H, Yamamoto H, Sakata Y, Asakura M, Higuchi Y, et al. Serial changes in plasma brain natriuretic peptide (BNP) concentration at the infarct and non-infarct sites in patients with left ventricular remodelling after myocardial infarction. Heart2005;17:215–20.Suche in Google Scholar
33. Nakayama T, Nomura M, Fujinaga H, Ikefuji H, Kimura M, Chikamori K, et al. Does coronary artery stenting for acute myocardial infarction improve left ventricular overloading at the chronic stage? Jpn Heart J2004;45:217–29.10.1536/jhj.45.217Suche in Google Scholar PubMed
34. Cameron VA, Rademaker MT, Ellmers LJ, Espiner EA, Nicholls MG, Richards AM. Atrial (ANP) and brain natriuretic peptide (BNP) expression after myocardial infarction in sheep: ANP is synthesized by fibroblasts infiltrating the infarct. Endocrinology2000;141:4690–7.10.1210/endo.141.12.7847Suche in Google Scholar PubMed
35. Takemura G, Fujiwara H, Yoshida H, Mukoyama M, Saito Y, Nakao K, et al. Identification and distribution of atrial natriuretic polypeptide in ventricular myocardium of humans with myocardial infarction. J Pathol1990;161:285–92.10.1002/path.1711610404Suche in Google Scholar PubMed
36. Yoshimura M, Yasue H, Okumura K, Ogawa H, Jougasaki M, Mukoyama M, et al. Different secretion pattern of natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation1993;87:464–9.10.1161/01.CIR.87.2.464Suche in Google Scholar
37. Saito Y, Nakao K, Arai H, Nishimura K, Okumura K, Obata K, et al. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest1989;83:298–305.10.1172/JCI113872Suche in Google Scholar PubMed PubMed Central
38. Rienstra M, Van Gelder IC, Van der Berg MP, Boomsma F, Van Veldhuisen DJ Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT)-ANP and (NT-pro)-BNP. Europace2006;8:482–7.10.1093/europace/eul060Suche in Google Scholar PubMed
©2007 by Walter de Gruyter Berlin New York
Artikel in diesem Heft
- Associations between folate, vitamin B12, homocysteine and pathologies related to aging: the need to consider complex nutrient-nutrient and gene-nutrient interactions and the functional and socio-economic determinants in population-based studies
- Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation
- Association of vitamin B12, folate and homocysteine with functional and pathological characteristics of the elderly in a mountainous village in Sicily
- Association of thyroid dysfunction with vitamin B12, folate and plasma homocysteine levels in the elderly: a population-based study in Sicily
- Desmond (Des) Kenny MSc MCB FICI FRCPath Eur Clin Chem, 1941–2006
- Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis
- Patient hydration: a major source of laboratory uncertainty
- Determination of the hepatitis C virus subtype: comparison of sequencing and reverse hybridization assays
- Quantification of relative changes in specific mRNAs from frozen whole blood – methodological considerations and clinical implications
- HER-2 protein concentrations in breast cancer cells increase before immunohistochemical and fluorescence in situ hybridization analysis turn positive
- Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis
- Novel molecular defect in the platelet ADP receptor P2Y12 of a patient with haemorrhagic diathesis
- Retrospective study of monoclonal gammopathies detected in the clinical laboratory of a Spanish healthcare district: 14-year series
- Renal impairment compromises the use of total homocysteine and methylmalonic acid but not total vitamin B12 and holotranscobalamin in screening for vitamin B12 deficiency in the aged
- Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome
- Amniotic fibronectin fragmentation and expression of its domains, sialyl and fucosyl glycotopes associated with pregnancy complicated by intrauterine infection
- Predicted influence of sample hematocrit on injected mass of internal standard in mass spectrometry assays utilizing simple protein precipitation for sample preparation
- Evaluation of cardiovascular risk factors and related clinical markers in healthy young Japanese adults
- Cardiac natriuretic peptides after myocardial infarction: relationship with infarct size, left ventricular function and remodelling assessed by 99mTc-sestamibi gated-single photon emission tomography
- Plasma homocysteine cutoff values for venous thrombosis
- Lipid transfer protein activities in subjects with impaired glucose tolerance
- Heat shock protein 70-1 gene expression in pediatric heart surgery using blood cardioplegia
- Biochemical reference intervals for sex hormones with a new AutoDelfia method in aged men
- The Italian External Quality Control Programme for cystic fibrosis molecular diagnosis: 4 years of activity
- Standardization of ischemia-modified albumin testing: adjustment for serum albumin
- Is simultaneous measurement of anti-thyroid peroxidase and anti-thyroglobulin antibodies clinically useful in patients with thyroid dysfunction?
- To the Editor: In reply to Nakano et al. Clin Chem Lab Med 2006;44(5):522–532
- To the Editor: Author reply; Nakano et al. Clin Chem Lab Med 2006;44(5):522–532
- Accreditation of medical laboratories in the European Union
- Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge
Artikel in diesem Heft
- Associations between folate, vitamin B12, homocysteine and pathologies related to aging: the need to consider complex nutrient-nutrient and gene-nutrient interactions and the functional and socio-economic determinants in population-based studies
- Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation
- Association of vitamin B12, folate and homocysteine with functional and pathological characteristics of the elderly in a mountainous village in Sicily
- Association of thyroid dysfunction with vitamin B12, folate and plasma homocysteine levels in the elderly: a population-based study in Sicily
- Desmond (Des) Kenny MSc MCB FICI FRCPath Eur Clin Chem, 1941–2006
- Antibodies to citrullinated peptides: a significant step forward in the early diagnosis of rheumatoid arthritis
- Patient hydration: a major source of laboratory uncertainty
- Determination of the hepatitis C virus subtype: comparison of sequencing and reverse hybridization assays
- Quantification of relative changes in specific mRNAs from frozen whole blood – methodological considerations and clinical implications
- HER-2 protein concentrations in breast cancer cells increase before immunohistochemical and fluorescence in situ hybridization analysis turn positive
- Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis
- Novel molecular defect in the platelet ADP receptor P2Y12 of a patient with haemorrhagic diathesis
- Retrospective study of monoclonal gammopathies detected in the clinical laboratory of a Spanish healthcare district: 14-year series
- Renal impairment compromises the use of total homocysteine and methylmalonic acid but not total vitamin B12 and holotranscobalamin in screening for vitamin B12 deficiency in the aged
- Diagnostic value of calculated testosterone indices in the assessment of polycystic ovary syndrome
- Amniotic fibronectin fragmentation and expression of its domains, sialyl and fucosyl glycotopes associated with pregnancy complicated by intrauterine infection
- Predicted influence of sample hematocrit on injected mass of internal standard in mass spectrometry assays utilizing simple protein precipitation for sample preparation
- Evaluation of cardiovascular risk factors and related clinical markers in healthy young Japanese adults
- Cardiac natriuretic peptides after myocardial infarction: relationship with infarct size, left ventricular function and remodelling assessed by 99mTc-sestamibi gated-single photon emission tomography
- Plasma homocysteine cutoff values for venous thrombosis
- Lipid transfer protein activities in subjects with impaired glucose tolerance
- Heat shock protein 70-1 gene expression in pediatric heart surgery using blood cardioplegia
- Biochemical reference intervals for sex hormones with a new AutoDelfia method in aged men
- The Italian External Quality Control Programme for cystic fibrosis molecular diagnosis: 4 years of activity
- Standardization of ischemia-modified albumin testing: adjustment for serum albumin
- Is simultaneous measurement of anti-thyroid peroxidase and anti-thyroglobulin antibodies clinically useful in patients with thyroid dysfunction?
- To the Editor: In reply to Nakano et al. Clin Chem Lab Med 2006;44(5):522–532
- To the Editor: Author reply; Nakano et al. Clin Chem Lab Med 2006;44(5):522–532
- Accreditation of medical laboratories in the European Union
- Prevalence-dependent decision limits for the early detection of type 2 diabetes mellitus in venous blood, venous plasma and capillary blood during glucose challenge
